Communication Compounding White Paper 
Pharma and Life Sciences Blog
NOVEMBER 22, 2023
The environment is marked by heightened demand and expectations, compounded by challenges such as rising input prices, supply chain disruptions and geopolitical tensions. While some embrace cutting-edge tools like AI and blockchain for global trade functions, others lag in technology adoption.
pharmaphorum
NOVEMBER 3, 2021
Using content metrics, companies can understand how their current content is received and engaged with, which will, in turn, helps clarify the most effective and efficient ways to connect and communicate with their audience in the future, resulting in increased speed to market and effective content engagement.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
epicur
FEBRUARY 23, 2023
Traditional 503A compounding pharmacies and 503B outsourcing manufacturers both serve as important partners for veterinary practices, providing patient-specific prescriptions and manufacturing bulk drugs for in-practice use and dispensing when allowed by state regulations. In many cases, those variances have led to compounding tragedies.
Pharmaceutical Technology
JANUARY 10, 2023
The collaboration will combine 3T Biosciences’ 3T- T-Cell Receptor Antigen and Cross-Reactivity Engine (TRACE) discovery platform with Boehringer Ingelheim’s two-pronged research strategy combining compounds that are directed towards cancer cells and target immune cells.
Pharmaceutical Technology
FEBRUARY 23, 2023
Our chemists and formulation scientists review the properties of new drug candidates and “work their magic” to develop formulations that improve the exposure profile of the compound. How does bioavailability play a role in biopharmaceutics? Now fraction absorbed and bioavailability are often confused and used interchangeably.
Pharmaceutical Technology
MARCH 6, 2023
Teijin Pharma is laying the foundation for quickly delivering a new therapy for patients globally by licensing the investigational compound to Novartis. It stated that the candidate is believed to impact the pathogenesis of several kidney diseases and works in a genetically validated pathway.
Pharmaceutical Technology
MARCH 20, 2023
These are mainly all those with a compound in BioNTech’s pipeline. Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
Expert insights. Personalized for you.
52 
Let's personalize your content